Abstract
Ubiquitin (Ub)-mediated proteasome-dependent proteolysis is critical in regulating multiple biological processes including apoptosis. We show that the unstructured BH3-only protein, NOXA, is degraded by an Ub-independent mechanism requiring 19S regulatory particle (RP) subunits of the 26S proteasome, highlighting the possibility that other unstructured proteins reported to be degraded by 20S proteasomes in vitro may be bona fide 26S proteasome substrates in vivo. A lysine-less NOXA (NOXA-LL) mutant, which is not ubiquitinated, is degraded at a similar rate to wild-type NOXA. Myeloid cell leukemia 1, but not other anti-apoptotic BCL-2 family proteins, stabilizes NOXA by interaction with the NOXA BH3 domain. Depletion of 19S RP subunits, but not alternate proteasome activator REG subunits, increases NOXA half-life in vivo. A NOXA-LL mutant, which is not ubiquitinated, also requires an intact 26S proteasome for degradation. Depletion of the 19S non-ATPase subunit, PSMD1 induces NOXA-dependent apoptosis. Thus, disruption of 26S proteasome function by various mechanisms triggers the rapid accumulation of NOXA and subsequent cell death strongly implicating NOXA as a sensor of 26S proteasome integrity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CHX:
-
cycloheximide
- MCL-1:
-
myeloid cell leukemia 1
- WT:
-
wild-type
- LL:
-
lysine-less
- BH:
-
Bcl-2 homology
- CP:
-
core particle
- RP:
-
regulatory particle
- t1/2:
-
half life
- HA:
-
hemagglutinin
- NTA:
-
nitriloacetic acid
References
Youle RJ, Strasser A . The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47–59.
Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393–403.
Hagenbuchner J, Ausserlechner MJ, Porto V, David R, Meister B, Bodner M et al. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. J Biol Chem 2010; 285: 6904–6912.
Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH . BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1 alpha. J Exp Med 2004; 199: 113–123.
Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y et al. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc Natl Acad Sci USA 2007; 104: 19488–19493.
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053–1058.
Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V et al. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 2005; 65: 6282–6293.
Baou M, Kohlhaas SL, Butterworth M, Vogler M, Dinsdale D, Walewska R et al. Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells. Haematologica 2010; 95: 1510–1518.
Fernandez Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW et al. Differential regulation of Noxa in normal melanocytes and melanoma cells by proteasome inhibition: Therapeutic implications. Cancer Res 2005; 65: 6294–6304.
Hershko A, Ciechanover A . The ubiquitin system. Ann Rev Biochem 1998; 67: 425–479.
Vucic D, Dixit VM, Wertz IE . Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol 2011; 12: 439–452.
Tsvetkov P, Reuven N, Shaul Y . The nanny model for IDPs. Nat Chem Biol 2009; 5: 778–781.
Jariel-Encontre I, Bossis G, Piechaczyk M . Ubiquitin-independent degradation of proteins by the proteasome. Biochim Biophys Acta 2008; 1786: 153–177.
Wiggins CM, Tsvetkov P, Johnson M, Joyce CL, Lamb CA, Bryant NJ et al. BimEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci 2011; 124: 969–977.
Stewart DP, Koss B, Bathina M, Perciavalle RM, Bisanz K, Opferman JT . Ubiquitin-independent degradation of antiapoptotic MCL-1. Mol Cell Biol 2010; 30: 3099–3110.
Schrader EK, Harstad KG, Matouschek A . Targeting proteins for degradation. Nat Chem Biol 2009; 5: 815–822.
Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A . A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J 1998; 17: 5964–5973.
Nijhawan D, Fang M, Traer E, Zhong Q, Gao WH, Du FH et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475–1486.
Shabek N, Herman-Bachinsky Y, Ciechanover A . Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc Natl Acad Sci USA 2009; 106: 11907–11912.
Ciechanover A, Ben-Saadon R . N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol 2004; 14: 103–106.
Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DCS et al. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 2007; 104: 6217–6222.
Asher G, Tsvetkov P, Kahana C, Shaul Y . A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 2005; 19: 316–321.
Chen XY, Barton LF, Chi Y, Clurman BE, Roberts JM . Ubiquitin-independent degradation of cell-cycle inhibitors by the REG gamma proteasome. Mol Cell 2007; 26: 843–852.
Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 1992; 360: 597–599.
Fricker M, O’Prey J, Tolkovsky AM, Ryan KM . Phosphorylation of puma modulates its apoptotic function by regulating protein stability. Cell Death Disease 2010; 1: e59.
Sandow JJ, Jabbour AM, Condina MR, Daunt CP, Stomski FC, Green BD et al. Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell death. Cell Death Differ 2011; e-pub ahead of print 14 October 2011.
Shibatani T, Ward WF . Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver. Arch Biochem Biophys 1995; 321: 160–166.
Wojcik C, DeMartino GN . Analysis of Drosophila 26 S proteasome using RNA interference. J Biol Chem 2002; 277: 6188–6197.
Hinds MG, Smits C, Fredericks-Short R, Risk JM, Bailey M, Huang DCS et al. Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 2007; 14: 128–136.
Zhong Q, Gao WH, Du FH, Wang XD . Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005; 121: 1085–1095.
Foerster F, Lasker K, Nickell S, Sali A, Baumeister W . Toward an integrated structural model of the 26S proteasome. Mol Cell Proteomics 2010; 9: 1666–1677.
Lopez H, Zhang L, George NM, Liu X, Pang X, Evans JJ et al. Perturbation of the Bcl-2 network and an induced Noxa/Bcl-xL interaction trigger mitochondrial dysfunction after DNA damage. J Biol Chem 2010; 285: 15016–15026.
Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-x(L), but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005; 19: 1294–1305.
Lee EF, Czabotar PE, Van Delft MF, Michalak EM, Boyle MJ, Willis SN et al. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation. J Cell Biol 2008; 180: 341–355.
Gomez-Bougie P, Menoret E, Juin P, Dousset C, Pellat-Deceunynck C, Amiot M . Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction. Biochem Biophys Res Commun 2011; 413: 460–464.
Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010; 463: 103–107.
Mei YD, Du WJ, Yang YH, Wu MA . Puma* Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene 2005; 24: 7224–7237.
Ewings KE, Hadfield-Moorhouse K, Wiggins CM, Wickenden JA, Balmanno K, Gilley R et al. ERK1/2-dependent phosphorylation of Bim(EL) promotes its rapid dissociation from Mcl-1 and Bcl-x(L). EMBO J 2007; 26: 2856–2867.
Letai AG . Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 2008; 8: 121–132.
Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT et al. Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia. J Clin Invest 2010; 120: 2109–2118.
Acknowledgements
These studies were supported by the Medical Research Council (London, UK). We thank Dr. X-M. Sun for ΔN-MCL-1 G262A protein and Dr. David Ross (University of Colorado, Boulder) for pcDNA3-NQO1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by G Melino
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Supplementary information
Rights and permissions
About this article
Cite this article
Craxton, A., Butterworth, M., Harper, N. et al. NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1. Cell Death Differ 19, 1424–1434 (2012). https://doi.org/10.1038/cdd.2012.16
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2012.16
Keywords
This article is cited by
-
Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status
Scientific Reports (2024)
-
The birth of death, 30 years ago
Cell Death & Differentiation (2024)
-
BCL-2 protein family: attractive targets for cancer therapy
Apoptosis (2023)
-
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
Nature Communications (2022)
-
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment
Cell Death Discovery (2022)
